INTERPACE BIOSCIENCES, INC. (IDXG) Net income 2016–2025
INTERPACE BIOSCIENCES, INC. (IDXG) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$24.6MFY2025 · since FY2016: -$22.0M → $24.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $24.6M | +266.7% |
| FY2024 | $6.7M | +243.0% |
| FY2023 | $2.0M | +108.9% |
| FY2022 | -$22.0M | -46.9% |
| FY2021 | -$14.9M | +43.5% |
| FY2020 | -$26.5M | +1.1% |
| FY2019 | -$26.7M | -110.5% |
| FY2018 | -$12.7M | -201.2% |
| FY2017 | $12.6M | +157.1% |
| FY2016 | -$22.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXG financial trends
IDXG RevenueIDXG Net marginIDXG Gross profitIDXG Gross marginIDXG Operating incomeIDXG Operating marginIDXG Operating cash flowIDXG Free cash flowIDXG Capital expendituresIDXG Return on equityIDXG Stock buybacksIDXG Dividends paidIDXG Total assetsIDXG Total liabilitiesIDXG Shareholders’ equityIDXG overview →